Thomas Woiwode, PhD

Tom Woiwode is a Managing Director who has been with Versant Ventures since 2002. Most recently, Tom served as the Chief Operating Officer of Okairos, a biopharmaceutical company developing genetic vaccines for major infectious diseases. Tom led the process that culminated in the sale of Okairos to GSK for $325M.

Prior to his role with Okairos, Tom co-founded EuroVentures, a wholly owned biotech incubator within Versant Ventures, and in this role, served as the founding Chief Business Officer for three biotech companies created within Versant: Flexion (public), Synosia (public, merged with Biotie), and Amira (acquired by BMS for up to $475M).

Tom was also Principal at Versant Ventures and served on the boards of Antipodean, Metabolex and Saegis. In addition, Tom was a research scientist at XenoPort before joining Versant.

 

Assistants

Nicoletta Mattarelli (Basel Assistant)

nmattarelli@versantventures.com

650-233-7877
Sarah Cross (USA Assistant)

scross@versantventures.com

(650) 233 7447

Personal

With Tom being a native Californian and surfer, you can often find him at the nearest beach trying to catch the next great wave. Tom resides in Basel-Switzerland with his wife and two daughters. Collectively as a family, with Europe as their backyard, they enjoy traveling the world together in search for Tom’s perfect wave.